scrutiny 发表于 2025-3-25 07:03:44

Submitted on: 10 June 2004.
Revised on: 06 October 2004.
Accepted on: 22 October 2004.

___________________Journal fur Hypertonie---KRAUSE & PACHERNEGG GMBH

filicide 发表于 2025-3-25 08:20:20

Submitted on: 25 October 1999.
Revised on: 05 February 2000.
Accepted on: 19 February 2000.

___________________Journal fur Hypertonie---KRAUSE & PACHERNEGG GMBH

Allure 发表于 2025-3-25 11:43:22

http://reply.papertrans.cn/2/151/15014/15014-23.png

表主动 发表于 2025-3-25 19:50:14

Submitted on: 15 December 2011.
Revised on: 28 February 2012.
Accepted on: 18 April 2012.

___________________Journal fur Hypertonie---KRAUSE & PACHERNEGG GMBH

尖牙 发表于 2025-3-25 22:06:21

Submitted on: 24 January 2012.
Revised on: 23 May 2012.
Accepted on: 11 June 2012.

___________________Journal fur Hypertonie---KRAUSE & PACHERNEGG GMBH

蒸发 发表于 2025-3-26 03:24:17

http://reply.papertrans.cn/2/151/15014/15014-26.png

blithe 发表于 2025-3-26 08:17:23

Submitted on: 27 December 2006.
Revised on: 19 February 2007.
Accepted on: 10 April 2007.

___________________Journal fur Hypertonie---KRAUSE & PACHERNEGG GMBH

非秘密 发表于 2025-3-26 11:08:00

http://reply.papertrans.cn/2/151/15014/15014-28.png

先锋派 发表于 2025-3-26 13:43:02

http://reply.papertrans.cn/2/151/15014/15014-29.png

antidepressant 发表于 2025-3-26 18:20:27

Submitted on: 22 June 2002.
Revised on: 28 September 2002.
Accepted on: 02 November 2002.

___________________Journal fur Hypertonie---KRAUSE & PACHERNEGG GMBH
页: 1 2 [3] 4
查看完整版本: ESCI期刊Journal fur Hypertonie 2024/2025影响因子:0.021 (J HYPERTON) (1028-2327). (CARDIAC & CARDIOVASCULAR SYSTEMS)(心脏与心血管系统)